Yesterday’s post referenced a number of readers who were critical of my “main stream” reporting concerning multiple myeloma related therapies. One of them, Margaret from Italy, makes this wonderful point in an e-mail I recieved from her a few days ago:
In the words of Prof. Aggarwal, who works in the Department of Experimental Therapeutics at the University of Texas M.D. Anderson Cancer Center, “If we continue to prevent and treat cancer the way we are currently doing and have been doing for the past 50 years, the next 50 years will not be any different. We have to learn to think outside the box. We have put too much emphasis on survival of the pharmaceutical companies and not enough focus on the survival of the patients.” Hear, hear.
Stable curcumin-taking SMM in Florence, Italy.
It’s hard to argue with logic like that! Thanks, Margaret!
Feel good and keep smiling! Pat